Satyanarayana Rachagani
Missouri University of Science and Technology(US)Missouri College(US)University of Missouri Hospital(US)University of Missouri Health System(US)Jewish Hospital(US)Harry S. Truman Memorial Veterans' Hospital(US)University of Nebraska Medical Center(US)University of Missouri(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Epigenetics and DNA Methylation, Cancer, Hypoxia, and Metabolism, Histone Deacetylase Inhibitors Research, Pancreatic function and diabetes
Most-Cited Works
- → Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1–CD44 Axis(2021)258 cited
- → Graviola: A novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism(2012)197 cited
- → Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance(2020)154 cited
- → Current status of mucins in the diagnosis and therapy of cancer(2009)148 cited
- → Pathobiological Implications of MUC16 Expression in Pancreatic Cancer(2011)141 cited
- → Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy(2013)137 cited